Abstract:OBJECTIVE:To explore the correlation of chemokines and chemokine receptors with clinical features of newly diagnosed systemic lupus erythematosus (SLE). METHODS:Samples of venous blood were collected from 37 newly diagnosed SLE patients, 2 males and 35 females, aged 32.5 (15-54), and 20 healthy controls. The serum concentration of macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta and reduced upon activation normal T cell expressed and secreted (RANTES) were measured by ELISA. Samples of anticoagulative serum were collected from 18 of the 37 newly diagnosed SLE patients and 10 healthy controls. The expression rates of CCR1, CCR3, and CCR5 on CD4+ T cells were detected by flow cytometry. Indirect immunofluorescence method was used to detect the anti-ds-DNA antibody, and blot immunoassay was used to detect the anti-RNP and anti-SSA antibodies. The associations of chemokines and chemokine receptors with the clinical features were analyzed. RESULTS:The serum concentration of MIP-1alpha of the SLE patients was (37 +/- 25) ng/L, significantly higher than that of the controls (8 +/- 9) ng/L (P < 0.001). The serum concentration of MIP-1beta of the SLE patients was (160 +/- 140) ng/L, significantly higher than that of the controls (76 +/- 41) ng/L (P = 0.003). The serum concentration of RANTES of the SLE patients was (184 +/- 22) ng/L, not significantly different from that of the controls (144 +/- 79) ng/L (P > 0.05). The serum concentration of MIP-1alpha of the SLE patients with fever was 52 ng/L +/- 27 ng/L, significantly higher than that of the SLE patients without fever (28 ng/L +/- 19 ng/L, P = 0.006). The serum concentration of MIP-1beta of the SLE patients with arthritis was 221 ng/L +/- 158 ng/L, significantly higher than that of the SLE patients without arthritis (95 ng/L +/- 83 ng/L, P = 0.008). The serum concentration of RANTES of the SLE patients with low blood platelet count was 130 ng/L +/- 122 ng/L, significantly lower than that of the SLE patients with normal blood platelet count (212 ng/L +/- 114 ng/L, P = 0.049). The percentage of CD4+ CCR3+ T cell subgroup in CD4+ T cell in peripheral blood of the SLE patients positive in anti-RNP antibody was 14.8% +/- 3.0%, significantly lower than that of the SLE patients negative in anti-RNP antibody (11.3% +/- 2.6%, P = 0.018). CONCLUSION:Abnormality of different chemokines and chemokine receptors may concern with different clinical features of SLE.

The Effect of C-reactive Protein (CRP) in Differenciation of Systemic Lupus Erythematosus Flare from Infection Complications

Aberrant T Cell Subsets and Cytokines Expression Profile in Systemic Lupus Erythematosus.

Relationship of serological features with disease status and infection in patients with systemic upus erythematosus (SLE)

THU0036 Discriminating Central Nervous System Infection and Neuropsychiatric Involvement in Patients with Systemic Lupus Erythematosus: A Single-Center Experience

Serum Procalcitonin and C-reactive Protein for Differentiating Bacterial Infection from Disease Activity in Patients with Systemic Lupus Erythematosus

Serum procalcitonin and C-reactive protein levels as diagnostic markers for distinguishing bacterial infections from lupus flares in systemic lupus erythematosus: A systematic review and meta‐analysis

Serum Level of Anti-Monomer C-reactive Protein Antibody in Systemic Lupus Erythematosus

C-reactive Protein Reflects the Severity of Active Inflammatory Bowel Disease

Discriminating Infectious Meningitis Versus Neuropsychiatric Involvement in Patients with Systemic Lupus Erythematosus: a Single-Center Experience

Infections in Systemic Lupus Erythematosus:Risk Factors,clinical Characteristics and Early Diagnosis

The Complex Role of C-Reactive Protein in Systemic Lupus Erythematosus

Clinical Study of Invasive Fungal Infection Secondary to Systemic Lupus Erythematosus

Combining C Reactive Protein and Serum Albumin to Predict 90-Day Mortality in Systemic Lupus Erythematosus with Serious Community-Acquired Infections

Infection-Associated Flares in Systemic Lupus Erythematosus

Levels of erythrocyte complement receptor type 1 in the pathogenesis of systemic lupus erythematosus

Correlation of Chemokines and Chemokine Receptors with Clinical Features in Newly Diagnosed Systemic Lupus Erythematosus

Studies on Expression of Chemokine Receptors CCR4 and CCR5 Mrna in Patients with Systemic Lupus Erythematosus

Expression and significance of erythrocyte complement receptor type 1 in patients with systemic lupus erythematosus

T Cell Subsets and Immunoglobulin G Levels Are Associated with the Infection Status of Systemic Lupus Erythematosus Patients

Risk Factors for Serious Infections in Inpatients with Systemic Lupus Erythematosus.

Association of Increased Serum IL-33 Levels with Clinical and Laboratory Characteristics of Systemic Lupus Erythematosus in Chinese Population.